MarketsStocksCOHANCE
CO

Cohance Lifesciences Ltd

NSE: COHANCEBSE: 543064Healthcare
Download Research Report7-page PDF
423.85
-1.68%
NSE · auto-updates while market open
Prev Close
₹1,055.10
Day High
₹430.00
Day Low
₹420.30
Mkt Cap
₹15,925 Cr
P / E
106.4
P / B
4.1
ROE
5.3%
52W High
₹1,121.15
52W Low
₹266.70
Key Metrics
Market Cap
₹15,925 Cr
P / E
106.36
P / B
4.07
EV / EBITDA
41.77
ROCE
8.4%
ROE
5.3%
Debt / Equity
0.04
Book Value
₹102.23
EPS
₹4.69
Div Yield
0.0%
Face Value
₹1
Promoter Holding
57.5%
Revenue · ₹ Cr
834
FY20
1.0k
FY21
1.3k
FY22
1.3k
FY23
1.1k
FY24
1.2k
FY25
2.3k
FY26
Net Profit · ₹ Cr
317
FY20
362
FY21
454
FY22
411
FY23
300
FY24
265
FY25
150
FY26
EPS · ₹ per share
₹24.9
FY20
₹14.2
FY21
₹17.8
FY22
₹16.2
FY23
₹11.8
FY24
₹10.5
FY25
₹4.7
FY26
P / E Ratio · price ÷ TTM EPS
12581051512090-1Jun 21Feb 23Oct 24Jun 26
P/E 96.4×Median 39.3×TTM EPS
Q1 2026 snapshot
Sales
₹617 Cr
Operating profit
-
OPM
-
Net profit
₹8 Cr
EPS
₹0.51
Scorecard · 7 axes
Quality
Weak
44/100
Valuation
Bad
106.4×
Growth
Bad
-4.8%
Profitability
Weak
6.8%
Performance
Bad
-59.5%
Entry Point
Strong
38%
Red Flags
Strong
0 flags
Shareholding Pattern
57.5%Promoter
Promoter57.5%
FII5.6%
DII21.8%
Public15.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue307.15412.59563.48556550.71617.28
Net Profit83.2938.7346.46629.028.31
NPM %27.1%9.4%8.2%11.9%5.3%1.3%
AlertPre-trade